Literature DB >> 26773498

SRSF3 represses the expression of PDCD4 protein by coordinated regulation of alternative splicing, export and translation.

Seung Kuk Park1, Sunjoo Jeong2.   

Abstract

Gene expression is regulated at multiple steps, such as transcription, splicing, export, degradation and translation. Considering diverse roles of SR proteins, we determined whether the tumor-related splicing factor SRSF3 regulates the expression of the tumor-suppressor protein, PDCD4, at multiple steps. As we have reported previously, knockdown of SRSF3 increased the PDCD4 protein level in SW480 colon cancer cells. More interestingly, here we showed that the alternative splicing and the nuclear export of minor isoforms of pdcd4 mRNA were repressed by SRSF3, but the translation step was unaffected. In contrast, only the translation step of the major isoform of pdcd4 mRNA was repressed by SRSF3. Therefore, overexpression of SRSF3 might be relevant to the repression of all isoforms of PDCD4 protein levels in most types of cancer cell. We propose that SRSF3 could act as a coordinator of the expression of PDCD4 protein via two mechanisms on two alternatively spliced mRNA isoforms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alterative splicing; Export; PDCD4; SRSF3; Translation

Mesh:

Substances:

Year:  2016        PMID: 26773498     DOI: 10.1016/j.bbrc.2016.01.019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis.

Authors:  Xianjuan Shen; Shan Kong; Shuo Ma; Lei Shen; Ming Zheng; Shiyi Qin; Jing Qi; Qiuhong Wang; Xiaopeng Cui; Shaoqing Ju
Journal:  Oncogene       Date:  2022-09-15       Impact factor: 8.756

Review 2.  SR Proteins: Binders, Regulators, and Connectors of RNA.

Authors:  Sunjoo Jeong
Journal:  Mol Cells       Date:  2017-01-26       Impact factor: 5.034

3.  p38 regulates the tumor suppressor PDCD4 via the TSC-mTORC1 pathway.

Authors:  Clarissa Braun; Karl Katholnig; Christopher Kaltenecker; Monika Linke; Nyamdelger Sukhbaatar; Markus Hengstschläger; Thomas Weichhart
Journal:  Cell Stress       Date:  2021-11-23

4.  Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.

Authors:  Jihua Guo; Xiaoxuan Che; Xiaole Wang; Rong Jia
Journal:  RSC Adv       Date:  2018-02-14       Impact factor: 4.036

Review 5.  Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer.

Authors:  Xiang Zheng; Qiu Peng; Lujuan Wang; Xuemei Zhang; Lili Huang; Jia Wang; Zailong Qin
Journal:  Int J Biol Sci       Date:  2020-07-06       Impact factor: 6.580

6.  SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.

Authors:  Yuki Kuranaga; Nobuhiko Sugito; Haruka Shinohara; Takuya Tsujino; Kohei Taniguchi; Kazumasa Komura; Yuko Ito; Tomoyoshi Soga; Yukihiro Akao
Journal:  Int J Mol Sci       Date:  2018-10-02       Impact factor: 5.923

Review 7.  Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment.

Authors:  Yanyan Chen; Mengxi Huang; Xiaolong Liu; Yadi Huang; Chao Liu; Jialong Zhu; Gongbo Fu; Zengjie Lei; Xiaoyuan Chu
Journal:  Cell Death Dis       Date:  2021-07-30       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.